Envestnet Portfolio Solutions Inc. Decreases Holdings in CME Group Inc. (NASDAQ:CME)

Envestnet Portfolio Solutions Inc. trimmed its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 30.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,809 shares of the financial services provider's stock after selling 20,612 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in CME Group were worth $12,418,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of the business. Lake Street Advisors Group LLC boosted its holdings in CME Group by 108.7% in the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider's stock worth $2,949,000 after acquiring an additional 6,453 shares in the last quarter. Unified Investment Management purchased a new position in shares of CME Group in the 4th quarter worth about $503,000. Aspire Growth Partners LLC bought a new position in CME Group in the 4th quarter worth about $548,000. First Citizens Bank & Trust Co. grew its position in CME Group by 3.4% during the 1st quarter. First Citizens Bank & Trust Co. now owns 43,135 shares of the financial services provider's stock valued at $11,443,000 after purchasing an additional 1,408 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA increased its stake in CME Group by 18.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,169,999 shares of the financial services provider's stock valued at $503,939,000 after purchasing an additional 343,498 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Bank of America increased their price target on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a report on Wednesday, April 2nd. Oppenheimer lifted their target price on CME Group from $282.00 to $300.00 and gave the stock an "outperform" rating in a report on Wednesday, June 4th. Piper Sandler upped their price target on CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Raymond James Financial raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a research report on Monday, March 10th. Finally, JPMorgan Chase & Co. decreased their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $258.20.

Insider Activity

In other CME Group news, Director Larry G. Gerdes sold 2,000 shares of the company's stock in a transaction on Thursday, April 24th. The stock was sold at an average price of $264.10, for a total value of $528,200.00. Following the completion of the sale, the director now directly owns 38,651 shares in the company, valued at approximately $10,207,729.10. This represents a 4.92% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Martin J. Gepsman sold 300 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $273.17, for a total transaction of $81,951.00. Following the transaction, the director now owns 24,767 shares of the company's stock, valued at approximately $6,765,601.39. This trade represents a 1.20% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,400 shares of company stock valued at $3,680,610. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Performance

Shares of CME traded up $1.89 on Friday, reaching $273.99. The company's stock had a trading volume of 10,636,035 shares, compared to its average volume of 2,239,945. The stock's 50 day simple moving average is $274.17 and its two-hundred day simple moving average is $255.42. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $98.74 billion, a P/E ratio of 27.56, a PEG ratio of 3.69 and a beta of 0.45. CME Group Inc. has a 12-month low of $192.11 and a 12-month high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The firm's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the company earned $2.50 EPS. Research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.82%. The ex-dividend date is Monday, June 9th. CME Group's payout ratio is 50.30%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.